RT Journal Article
SR Electronic
T1 Demarcation line determination for diagnosis of gastric cancer disease range using unsupervised machine learning in magnifying narrow-band imaging
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.03.20189472
DO 10.1101/2020.11.03.20189472
A1 Okumura, Shunsuke
A1 Goudo, Misa
A1 Hiwa, Satoru
A1 Yasuda, Takeshi
A1 Kitae, Hiroaki
A1 Yasuda, Yuriko
A1 Tomie, Akira
A1 Omatsu, Tatsushi
A1 Ichikawa, Hiroshi
A1 Yagi, Nobuaki
A1 Hiroyasu, Tomoyuki
YR 2022
UL http://medrxiv.org/content/early/2022/05/06/2020.11.03.20189472.abstract
AB Objectives It is important to determine an accurate demarcation line (DL) between the cancerous lesions and background mucosa in magnifying narrow-band imaging (M-NBI)-based diagnosis. However, it is difficult for novice endoscopists. Our aim was to automatically determine the accurate DL using a machine learning method.Methods We used an unsupervised machine learning approach to determine the DLs because it can reduce the burden of training machine learning models and labeling large datasets. Our method consists of the following four steps: 1) An M-NBI image is segmented into superpixels (a group of neighboring pixels) using simple linear iterative clustering. 2) The image features are extracted for each superpixel. 3) The superpixels are grouped into several clusters using the k-means method. 4) The boundaries of the clusters are extracted as DL candidates. To validate the proposed method, 23 M-NBI images of 11 cases were used for performance evaluation. The evaluation investigated the similarity of the DLs identified by endoscopists and our method, and the Euclidean distance between the two DLs was calculated. For the single case of 11 cases, the histopathological examination was also conducted and was used to evaluate the proposed system.Results The average Euclidean distances for the 11 cases were10.65, 11.97, 7.82, 8.46, 8.59, 9.72, 12.20, 9.06, 22.86, 8.45, and 25.36. The results indicated that the specific selection of the number of clusters enabled the proposed method to detect DLs that were similar to those of the endoscopists. The DLs identified by our method represented the complex shapes of the DLs, similarly to those identified by experienced doctors. Also, it was confirmed that the proposed system could generate the pathologically valid DLs by increasing the number of clusters.Conclusions Our proposed system can support the training of inexperienced doctors, as well as enrich the knowledge of experienced doctors in endoscopy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe would like to thank Editage (www.editage.com) for English language editing.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Endoscopic images obtained from October 2014 to December 2015 were used to establish the artificial intelligence (AI) system for the diagnosis of the disease range of gastric cancer. Those images were anonymized for the sake of personal information is not specified. This study was approved by the ethics committee of the Asahi University Hospital (registration number: 2020-05-01) and was conducted in accordance with the Helsinki Declaration of the World Medical Association. In this study, advanced expertise was required for processing images and making diagnostic algorithms. Therefore, all patients or the public were not involved in the design, conduct, reporting, and dissemination plans of our research.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data relevant to the study are included in the article.